BAMCO Inc
MRNA icon

BAMCO Inc’s Moderna MRNA Stock Holding History

BAMCO Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139M Buy
+1,989,386
New +$103M 0.21% 48
2024
Q1 		– Sell
-7,500
Closed -$746K – 339
2023
Q4 		$746K Sell
7,500
-419,369
-98% -$35.3M ﹤0.01% 307
2023
Q3 		$44.1M Buy
426,869
+418,269
+4,864% +$46.7M 0.13% 130
2023
Q2 		$1.04M Sell
8,600
-4,900
-36% -$654K ﹤0.01% 307
2023
Q1 		$2.07M Sell
13,500
-16,500
-55% -$2.72M 0.01% 298
2022
Q4 		$5.39M Buy
30,000
+13,000
+76% +$2.13M 0.02% 266
2022
Q3 		$2.01M Buy
17,000
+5,300
+45% +$804K 0.01% 309
2022
Q2 		$1.67M Buy
+11,700
New +$1.67M 0.01% 329
2022
Q1 		– Sell
-2,532
Closed -$643K – 407
2021
Q4 		$643K Sell
2,532
-46,800
-95% -$13.7M ﹤0.01% 382
2021
Q3 		$19M Sell
49,332
-15,950
-24% -$5.88M 0.04% 260
2021
Q2 		$15.3M Buy
65,282
+21,100
+48% +$3.77M 0.04% 273
2021
Q1 		$5.79M Buy
44,182
+40,382
+1,063% +$5.85M 0.01% 314
2020
Q4 		$397K Buy
+3,800
New +$384K ﹤0.01% 351
2020
Q3 		– Sell
-1,000
Closed -$64K – 367
2020
Q2 		$64K Buy
+1,000
New +$54.8K ﹤0.01% 327

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

BAMCO Inc's MRNA Position: Q2 2026 in Review

BAMCO Inc opened a new position in Moderna (MRNA) in Q2 2026: 1,989,386 shares worth $139M. The stake represents 0.21% of the portfolio and ranks #48 among its holdings. This is a return to the name: BAMCO Inc previously reported a position in MRNA as recently as Q4 2023.

BAMCO Inc first reported a position in MRNA in Q2 2020 and has held it in 14 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • BAMCO Inc held 1,989,386 shares of Moderna worth $139M as of Q2 2026.
  • Moderna was a new BAMCO Inc position in Q2 2026.
  • Moderna made up 0.21% of BAMCO Inc's portfolio in Q2 2026, its #48 holding.
  • BAMCO Inc first reported a position in Moderna in Q2 2020 and has held it in 14 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.